Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Aspirin in Maternal Endothelial Dysfunction and Uterine Artery Blood Flow in Women at Risk for Preeclampsia

NCT03893630 is registered in ClinicalTrials.gov with John O'Brien, MD as lead sponsor.

NCT NCT03893630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03893630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Aspirin in Maternal Endothelial Dysfunction and Uterine Artery Blood Flow in Women at Risk for Preeclampsia
Lead sponsor
John O'Brien, MD
Phase
Phase 2
Overall status
Completed
Start date
April 25, 2019
Completion date
September 28, 2022
Enrollment
208 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pre-eclampsia